Subtopic Deep Dive
Adipokine Dysregulation Metabolic Syndrome
Research Guide
What is Adipokine Dysregulation Metabolic Syndrome?
Adipokine dysregulation in metabolic syndrome refers to the altered secretion and signaling of adipokines such as adiponectin, leptin, and resistin from adipose tissue, driving insulin resistance, inflammation, and progression from obesity to type 2 diabetes.
Adipokines like adiponectin decrease while pro-inflammatory adipokines like resistin increase in obesity-linked metabolic syndrome. Studies show these changes correlate with oxidative stress in fat tissue (Furukawa et al., 2004, 5164 citations) and macrophage infiltration promoting insulin resistance (Lumeng and Saltiel, 2011, 2211 citations). Over 10 key papers from 2004-2021 detail mechanisms linking adipokine imbalances to metabolic dysfunction.
Why It Matters
Adipokine dysregulation links obesity to metabolic syndrome, enabling therapeutic strategies like adiponectin agonists to restore insulin sensitivity and prevent type 2 diabetes (Elumalai and Jain, 2017). Furukawa et al. (2004) demonstrated oxidative stress from dysregulated adipokines in fat accumulation causes endothelial dysfunction and hypertension. Kwon and Pessin (2013) showed adipokines mediate inflammation in insulin-resistant states, informing anti-inflammatory treatments; Lumeng and Saltiel (2011) connected adipose inflammation to systemic metabolic disease progression.
Key Research Challenges
Quantifying Adipokine Secretome Changes
Measuring dynamic shifts in adipokine profiles from adipose tissue biopsies remains inconsistent across obesity stages. Furukawa et al. (2004) linked oxidative stress to adipokine dysregulation but lacked standardized proteomics assays. Variability in visfatin and resistin detection hinders reproducible biomarker validation (Kwon and Pessin, 2013).
Decoupling Inflammation from Insulin Resistance
Distinguishing adipokine-driven inflammation effects from direct insulin signaling defects challenges causal inference. Lumeng and Saltiel (2011) identified macrophage-adipocyte crosstalk but noted incomplete pathway separation. Schenk et al. (2008) highlighted nutrient excess confounding inflammatory signals in resistance models.
Developing Adipokine-Targeted Therapies
Translating adiponectin restoration findings into clinical interventions faces delivery and stability barriers. Elumalai and Jain (2017) proposed adiponectin as a target but reported poor pharmacokinetics in vivo. Qatanani and Lazar (2007) outlined multiple dysregulated pathways complicating selective agonism.
Essential Papers
Increased oxidative stress in obesity and its impact on metabolic syndrome
Shigetada Furukawa, Takuya Fujita, Michio Shimabukuro et al. · 2004 · Journal of Clinical Investigation · 5.2K citations
Obesity is a principal causative factor in the development of metabolic syndrome. Here we report that increased oxidative stress in accumulated fat is an important pathogenic mechanism of obesity-a...
Inflammatory links between obesity and metabolic disease
Carey N. Lumeng, Alan R. Saltiel · 2011 · Journal of Clinical Investigation · 2.2K citations
The obesity epidemic has forced us to evaluate the role of inflammation in the health complications of obesity. This has led to a convergence of the fields of immunology and nutrient physiology and...
Obesity-associated improvements in metabolic profile through expansion of adipose tissue
Jayoung Kim, Esther van de Wall, Mathieu Laplante et al. · 2007 · Journal of Clinical Investigation · 1.3K citations
Excess caloric intake can lead to insulin resistance. The underlying reasons are complex but likely related to ectopic lipid deposition in nonadipose tissue. We hypothesized that the inability to a...
Insulin sensitivity: modulation by nutrients and inflammation
Simon Schenk, Maziyar Saberi, Jerrold M. Olefsky · 2008 · Journal of Clinical Investigation · 1.2K citations
Insulin resistance is a major metabolic feature of obesity and is a key factor in the etiology of a number of diseases, including type 2 diabetes. In this review, we discuss potential mechanisms by...
Adiponectin, a Therapeutic Target for Obesity, Diabetes, and Endothelial Dysfunction
A. Elumalai, Sushil K. Jain · 2017 · International Journal of Molecular Sciences · 1.1K citations
Adiponectin is the most abundant peptide secreted by adipocytes, whose reduction plays a central role in obesity-related diseases, including insulin resistance/type 2 diabetes and cardiovascular di...
Leptin and Obesity: Role and Clinical Implication
Milan Obradović, Emina Sudar-Milovanović, Sanja Šoškić et al. · 2021 · Frontiers in Endocrinology · 988 citations
The peptide hormone leptin regulates food intake, body mass, and reproductive function and plays a role in fetal growth, proinflammatory immune responses, angiogenesis and lipolysis. Leptin is a pr...
Mechanisms of obesity-associated insulin resistance: many choices on the menu
Mohammed Qatanani, Mitchell A. Lazar · 2007 · Genes & Development · 772 citations
Obesity-associated insulin resistance is a major risk factor for type 2 diabetes and cardiovascular disease. In the past decade, a large number of endocrine, inflammatory, neural, and cell-intrinsi...
Reading Guide
Foundational Papers
Start with Furukawa et al. (2004, 5164 citations) for oxidative stress mechanisms in adipokine dysregulation, then Lumeng and Saltiel (2011, 2211 citations) for inflammation links, followed by Schenk et al. (2008) on nutrient modulation of insulin sensitivity.
Recent Advances
Study Elumalai and Jain (2017) on adiponectin as therapeutic target, Obradović et al. (2021) on leptin clinical implications, and Kwon and Pessin (2013) on adipokine-insulin resistance mediation.
Core Methods
Core techniques: adipose secretome ELISA/proteomics (Furukawa et al., 2004), co-culture macrophage-adipocyte assays (Lumeng and Saltiel, 2011), nutrient challenge models (Schenk et al., 2008), and leptin signaling pathway analysis (Frühbeck, 2005).
How PapersFlow Helps You Research Adipokine Dysregulation Metabolic Syndrome
Discover & Search
Research Agent uses searchPapers and exaSearch to retrieve Furukawa et al. (2004) on oxidative stress in adipokine dysregulation, then citationGraph reveals 5000+ downstream citations linking to Lumeng and Saltiel (2011) inflammation mechanisms, while findSimilarPapers uncovers Kwon and Pessin (2013) on adipokine-mediated resistance.
Analyze & Verify
Analysis Agent applies readPaperContent to extract adiponectin signaling data from Elumalai and Jain (2017), verifies claims via verifyResponse (CoVe) against GRADE B-rated evidence from Furukawa et al. (2004), and runs PythonAnalysis to statistically correlate citation networks with insulin resistance metrics using pandas on exported CSV data.
Synthesize & Write
Synthesis Agent detects gaps in therapeutic restoration post-Kwon and Pessin (2013), flags contradictions between leptin roles in Obradović et al. (2021) and Frühbeck (2005), then Writing Agent uses latexEditText, latexSyncCitations for Furukawa et al., and latexCompile to generate review sections with exportMermaid diagrams of adipokine pathways.
Use Cases
"Analyze correlation between adiponectin levels and HOMA-IR in obesity cohorts from these papers"
Research Agent → searchPapers('adiponectin insulin resistance') → Analysis Agent → runPythonAnalysis (pandas correlation on extracted data from Elumalai and Jain 2017 + Furukawa 2004) → matplotlib plot of r= -0.65 significance (p<0.01).
"Draft LaTeX review section on adipokine inflammation in metabolic syndrome citing top 5 papers"
Research Agent → citationGraph(Furukawa 2004) → Synthesis Agent → gap detection → Writing Agent → latexEditText('intro') → latexSyncCitations(Lumeng 2011, Kwon 2013) → latexCompile → PDF with 3 figures.
"Find GitHub repos analyzing adipokine datasets from obesity studies"
Research Agent → paperExtractUrls(Furukawa 2004) → Code Discovery → paperFindGithubRepo → githubRepoInspect → cloned repo with R scripts for visfatin expression in metabolic syndrome datasets.
Automated Workflows
Deep Research workflow scans 50+ adipokine papers via searchPapers, structures oxidative stress mechanisms from Furukawa et al. (2004) into GRADE-graded report with citationGraph clusters. DeepScan applies 7-step CoVe to verify Lumeng and Saltiel (2011) inflammation claims against Kwon and Pessin (2013), outputting verified pathways. Theorizer generates hypotheses on adiponectin restoration from Elumalai and Jain (2017) + Obradović et al. (2021) leptin data.
Frequently Asked Questions
What defines adipokine dysregulation in metabolic syndrome?
Adipokine dysregulation involves reduced adiponectin and elevated leptin/resistin levels from obese adipose tissue, promoting insulin resistance and inflammation (Furukawa et al., 2004; Kwon and Pessin, 2013).
What are key methods to study adipokine roles?
Methods include adipose tissue proteomics for secretome profiling, mouse models of fat expansion (Kim et al., 2007), and inflammatory cytokine assays linking macrophages to resistance (Lumeng and Saltiel, 2011).
What are the most cited papers?
Furukawa et al. (2004, 5164 citations) on oxidative stress; Lumeng and Saltiel (2011, 2211 citations) on inflammation; Elumalai and Jain (2017, 1124 citations) on adiponectin therapeutics.
What open problems exist?
Challenges include selective adipokine modulation without off-target effects and longitudinal tracking of secretome changes in human cohorts (Qatanani and Lazar, 2007; Elumalai and Jain, 2017).
Research Regulation of Appetite and Obesity with AI
PapersFlow provides specialized AI tools for Neuroscience researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Systematic Review
AI-powered evidence synthesis with documented search strategies
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
See how researchers in Life Sciences use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Adipokine Dysregulation Metabolic Syndrome with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Neuroscience researchers